Hjem › Lungecancer › Rhode Island › Providence
Lungecancer kliniske forsøg i Providence, RI
4 studier for Lungecancer søger deltagere på steder i og omkring Providence (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Rhode Island Hospital, Providence
- Roger Williams Medical Center, Providence
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Lifespan Cancer Institute, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Providence
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
RekruttererFase 2
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
Lungecancer forsøg i andre byer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Washington, DC41 studier
- Arlington, VA41 studier
- Chicago, IL41 studier
- Nashville, TN40 studier
- Baltimore, MD40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andre studier i Providence
- Ægstockræft15 studier
- Livmoderslimhindekræft14 studier
- Overvægt14 studier
- Ikke-småcellet lungecancer12 studier
- Kræft (alle typer)12 studier
- Crohns sygdom12 studier
- Ulcerøs colitis11 studier
- Brystkræft11 studier
- Akut myeloid leukæmi10 studier
- Metastatisk cancer9 studier
- Overvægt9 studier
- Alzheimers sygdom8 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.